The Muscular Dystrophy Association (MDA)’s 2022 clinical and scientific conference will be held March 13-16 both virtually and in person at the Gaylord Opryland Resort and Convention Center in Nashville, Tennessee. Registration is now open.

“After 2 years of uncertainty around the world, we are excited to convene our professional community in two ways,” the MDA said in their conference prospectus. “While we are anxious to get back to “normal” we recognize that traveling as we have in the past may not be a possibility for all right now and we will offer all our first-in-class content via live-stream in a fully virtual environment as well as together [in person].”

The focus of this year’s conference will be the different aspects of research and care across neuromuscular diseases, including Duchenne muscular dystrophy (DMD), with the aim to develop better care and treatments for patients affected by these diseases. 


Continue Reading

Topics covered will range from new gene discoveries in neuromuscular diseases and the impact of gene transfer therapy on long-term multidisciplinary care to facilitating multipractice collaboration to optimize patient care and the evolution of ultra-rare disease clinical trial design. The full agenda will be available soon on the MDA’s conference website.

The conference is open to researchers, clinicians, and academicians as well as industry and government representatives and investors. The MDA also encourages the participation of patient advocacy organizations to ensure that the neuromuscular disease community is represented at the conference. 

Registration can be completed through the MDA’s conference website. Patients advocates and advocacy representatives will receive a reduced registration fee and have access to all sessions. 

Participants can submit their abstracts through the abstract submission portal. Oral presentations will be selected from abstracts that are submitted by December 31, 2021.

Last year’s conference was attended by 1261 delegates and featured 140 speakers and 25 exhibitors. There were 16 clinical trials sessions, 7 preclinical sessions, and 7 combined sessions.

Reference

Registration now open for 2022 MDA clinical & scientific conference, to showcase cutting edge research advancements and clinical achievements in neuromuscular diseases. New release. Muscular Dystrophy Association. September 27, 2021.